Tsang, Victoria S. K.
Riccio, Federica
Wilson, Aimee S.
Nudds, Hannah
Coombes, Jason D.
Wurdak, Heiko
Bulstrode, Harry J. C. J.
Lieberam, Ivo
Danovi, Davide
Funding for this research was provided by:
Wellcome Trust (108874/Z/15/Z)
Innovate UK (TSB/89370)
Medical Research Council (MR/N025865/1)
Rosetrees Trust
Article History
Received: 4 September 2025
Accepted: 27 November 2025
First Online: 13 December 2025
Competing interests
: D.D. is co-founder of Migration Biotherapeutics. He is a visiting academic at King’s College London and the Cambridge Stem Cell Institute and not an employee of either institution. The rest of the authors declare no competing interests.